MichaelPPoirierMD
Pediatric Emergency Medicine • Norfolk, VAAssociate Professor, Pediatrics, Eastern Virginia Medical School
Are you Dr. Poirier?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 44 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
601 Childrens Ln
Norfolk, VA 23507Phone+1 757-668-9222Fax+1 757-668-7568
Summary
- Dr. Michael Poirier, MD is a pediatric emergency medicine physician in Norfolk, Virginia. He is currently licensed to practice medicine in Virginia, Ohio, and Georgia. He is affiliated with Children's Hospital of The King's Daughters and is an Associate Professor at Eastern Virginia Medical School.
Education & Training
University of Alabama Medical CenterResidency, Pediatrics, 1990 - 1993
University of Alabama School of MedicineClass of 1990
Certifications & Licensure
VA State Medical License 1996 - 2026
OH State Medical License 1994 - 1996
GA State Medical License 1993 - 1995
AL State Medical License 1991 - 1993- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Emergency Medicine
Awards, Honors, & Recognition
- Fellow (FACEP) American College of Emergency Physicians
- Fellow (FAAP) American Academy of Pediatrics
Publications & Presentations
PubMed
- 14 citationsEvaluation of an ambu-bag valve with a self-contained, colorimetric end-tidal CO2 system in the detection of airway mishaps: an animal trial.Gonzalez del Rey Ja, Poirier Mp, Digiulio Ga
Pediatric Emergency Care. 2000-04-01 - 79 citationsUtility of monitoring capnography, pulse oximetry, and vital signs in the detection of airway mishaps : a hyperoxemic animal modelMichael P. Poirier, Javier A Gonzalez Del-Rey, Constance M. McAneney, Gregg A. DiGiulio
The American Journal of Emergency Medicine. 1998-07-01 - 21 citationsA Prospective Study of the “Two-Bag System” in Diabetic Ketoacidosis ManagementMichael P. Poirier, David Greer, Marta Satin-Smith
Clinical Pediatrics. 2004-11-01
Press Mentions
- Qualigen Calls It Quits on COVID Antiviral After Pouring Millions into R&DAugust 17th, 2021
- Qualigen Therapeutics, Inc. Provides Update on Product Development Priorities and Reports Second Quarter and Six Month 2021 Financial ResultsAugust 17th, 2021
- Qualigen Therapeutics, Inc. Announces Submission of Investigational New Drug (IND) Application for QN-165, for the Treatment of COVID-19July 14th, 2021
- Join now to see all
Professional Memberships
- Fellow
- Fellow
